Follow-up on corrections·October 19, 2022

**This report was amended on 11/17/22 only to obtain a signature from the facility on the 9099/9099C pages as it was inadvertently not obtained when the report was delivered on 10/19/22. There are no other changes.** Licensing Program Analyst (LPA) Sabrina Calzada arrived at the facility unannounced to continue a complaint investigation. LPA met with Lacy Berry, Administrator and explained the purpose of the visit. LPA later met with Veronica Sison, Resident Care Coordinator. Prior to initiating the complaint visit, LPA completed required COVID-19 protocols, and wore the following Personal Protective Equipment (PPE): surgical mask. Additionally, LPA was screened by facility staff upon entering the facility. While at the facility, interviewing several residents, LPA observed the following deficiencies: At approximately 10:00 am, at the start of interviewing resident (R1), LPA observed R1 to have poured cough syrup on her breakfast tray. R1 stated the medication was delivered to her for her to take, before she eats breakfast, due to stomach issues. LPA notified a Med-Tech (S1) that staff must watch residents take their medication as part of administering it. LPA observed R1 to take the cough syrup in the presence of S1. Additionally, LPA observed nasal spray to be sitting on R1's night stand, unsecured. At approximately 11:00 am, LPA observed resident (R2) to be sitting near the door to her room that was partially opened, while opening a small bottle of medication and pouring 2-3 tablets in her hand. LPA knocked on the door to request to interview resident. LPA observed resident put the tablets back in the bottle and place the bottle in the storage area of her walker next to her. At approximately 1:00 pm, LPA observed resident (R3) to be sitting in her room with the door open and to have a bottle of Glucose tablets (50) in her room on a table. R4 immediately took the bottle and placed it in a drawer on the other side of her room. LPA spoke to Administrator about it who confirmed the RCC removed the bottle from R3's room around 4:15 pm today. cont on 809C(1)... 809C(1)..At approximately 1:30 pm, LPA observed resident's (R4)'s room open and R4 to be sitting in his room, using oxygen. LPA observed multiple tanks in his room. R4 told LPA he uses an inhaler in the morning and another one in the evening and showed LPA he had both inhalers stored in an unlocked drawer. LPA observed a small bottle of Ibuprofen to also be in the drawer with the inhalers. LPA discussed the situation with Administrator who requested RCC remove the Ibuprofen immediately. R4 stated to LPA until recently he kept both inhalers on the top of his dresser and was asked by a NOC staff to put them in the drawer. Administrator provided a copy of a physician's order stating R4 is authorized to keep Tiotropium-Olodaterol (Stiolto Respimat) 2.5-2.5 mcg/actuation Inhl Mist in his room and agreed to arrange for him to get a lock box for R4 to keep the inhalers in. At approximately 3:40 pm, LPA and Administrator discussed medication with resident (R5) in his room and asked if he was storing any in his room LPA and Administrator observed R5 open a top drawer of his dresser and pick up a medication cup containing (5) tablets, (4) white tablets and (1) red tablet. Administrator immediately requested R5 give her the medication and explained that it has to be secured with all of the other medications. Per California Code of Regulations, Title 22, Division 6, Chapter 8, the following (1) deficiency is cited on the 809D page. Exit interview. Copy of appeal rights provided.